Logo

Gene by Gene

Forensic Genomics Firm Othram Raises $4M

The company also said it has been awarded a research sequencing grant from Illumina Accelerator.

Family Tree DNA Challenges Alaska Genetic Privacy Law in Wake of Lawsuit
Premium

Parent firm Gene by Gene calls the law "brief and vague" and is pushing for ancestry testing to be exempt from the provision of the genetic privacy statute.

Consumer Genomics Market Should Pass 'Tipping Point' of 3 Million Samples Tested in 2015
Premium

The value of consumer genomics services is increasing as customers seek to discover new cousins and adoptees track down their biological birth parents.

For Consumer Genomics Market, 2014 was a Year of New Features, New Players, and 'Unmatched' Sales
Premium

Consumer genomics companies have seen their databases swell with hundreds of thousands of new samples, introduced diverse offerings, and adjusted to new competitors.

23andMe Scientists Offer Closer Look at Ancestry Composition Analysis Tool in New Paper
Premium

NEW YORK (GenomeWeb) – Scientists from consumer genomics firm 23andMe for the first time described the Mountain View, Calif.-based company's Ancestry Composition tool in a paper.

Apr 1, 2014

Gene by Gene Plans US Launch for Clinical Carrier Screening Array Focused on Jewish Populations
Premium

Mar 18, 2014

Family Tree DNA's NGS-Based 'BigY' Service to Inform Future Generations of Ancestry Testing Chips
Premium

Feb 25, 2014

Questions Abound about 23andMe's Ancestry Testing Business at RootsTech Conference
Premium

Feb 18, 2014

At RootsTech, Consumer Genomics Players, Observers Discuss New Trends, Tools, and Chips
Premium

Feb 18, 2014

Gene by Gene's Clinical, Research Arrays Exempt from New Myriad BRCA Testing Agreement
Premium

Feb 7, 2014

Gene by Gene Settles BRCA Patent Infringement Suit with Myriad Genetics, Other IP Owners

Dec 17, 2013

Citing Throughput Advantages, FTDNA Joins 23andMe in Moving to New 24-Sample Illumina Chip Format
Premium

Nov 12, 2013

Family Tree DNA Expands beyond Array-based Offerings with New Y Chromosome Sequencing Service
Premium

Oct 22, 2013

Myriad Sues Third Firm, BioReference's GeneDx, Alleging BRCA1/2 Patent Infringement

Oct 1, 2013

With Sequencing Ancestry Test Launch, Startup Full Genomes Enters Array-Dominated Market
Premium

Aug 28, 2013

GeneDx Launches Suite of Inherited Cancer Panels, Including BRCA1 and BRCA2 Genes
Premium

Aug 15, 2013

Gene by Gene Joins Ambry in Countersuit against Myriad Alleging Antitrust Violations

Aug 9, 2013

Gene by Gene Acquires Arpeggi to Extend Genetic Testing and Diagnostic Offerings
Premium

Aug 7, 2013

Not Backing Down in BRCA Test Infringement Case, Ambry Slaps Myriad with Antitrust Countersuit
Premium

Aug 7, 2013

Gene by Gene Buys Arpeggi in a Deal to Accelerate Genetic Testing, Dx Services

Jul 10, 2013

Myriad, Others Sue Gene by Gene Alleging Infringement of BRCA 1/2 Patents

Jul 10, 2013

In Warning to Would-be Competitors, Myriad and BRCA Test Patent Holders Sue Ambry, Gene by Gene
Premium

Jun 19, 2013

With New BRCA Testing Options, Patient Groups Advise Women to Speak to Genetics Expert, Share Reports
Premium

Apr 24, 2013

Gene by Gene, MD Anderson to Boost Aspiring Molecular Genetic Technologists' NGS Skills
Premium

Apr 23, 2013

Gene By Gene to Support MD Anderson Genomics Education Program

Breaking News
The Scan

Should've Been Spotted Sooner

Scientists tell the Guardian that SARS-CoV-2 testing issues at a UK lab should have been noticed earlier.

For Martian Fuel

Researchers have outlined a plan to produce rocket fuel on Mars that uses a combination of sunlight, carbon dioxide, frozen water, cyanobacteria, and engineered E. coli, according to Gizmodo.

To Boost Rapid Testing

The Washington Post writes that new US programs aim to boost the availability of rapid at-home SARS-CoV-2 tests.

PNAS Papers on Strawberry Evolution, Cell Cycle Regulators, False-Positive Triplex Gene Editing

In PNAS this week: strawberry pan-genome, cell cycle-related roles for MDM2 and MDMX, and more.